The notice arrives on a Tuesday. A hospice two counties over — one you have referred to, one whose director you know from the state association — has had its Medicare payments suspended. Not shut down for fraud. Suspended. Swept into the same net that was cast for the operators billing for patients who were never eligible, never visited, in some cases never even aware they had been enrolled.
The director keeps saying the same thing on the phone: we did nothing wrong. And he is probably right. But “we did nothing wrong” is not a document. It is not in the chart. And the people deciding whether his agency gets turned back on have never met him, never sat in his IDG, never watched his nurses work a 3 a.m. crisis call. They are reading his notes. That is all they have.
The net is wide, and it is catching everyone
Let me be clear about the environment, because the reframe only works if we name it honestly. The fraud is real, and the enforcement is overdue. Schemes in a handful of states have bilked Medicare of millions of dollars meant for dying patients, enrolling vulnerable seniors without informed consent and trading on their benefit. Patients and families have been genuinely harmed. Anyone who has spent a career in this field wants those operators stopped.
So the crackdown is justified. Six states — Arizona, California, Nevada, Texas, and more recently Georgia and Ohio — are under enhanced oversight. A national moratorium has paused new hospice and home health Medicare enrollment into December. A federal strike force pulling together the FBI, DOJ, the HHS Office of Inspector General, and the DEA has driven hundreds of California license suspensions. Few of us would argue the problem did not warrant a serious response.
But the net is wide. Legitimate providers are being caught in the dragnet, and once a program is shuttered, the path back to reinstatement is slow and uncertain. Legal experts are now telling agencies they need a “bulletproof” approach to compliance. Regulators, the trade press reports, are closely watching three things in particular: eligibility criteria, recertification patterns, and discharge rates. Read that list again. Every item on it is a documentation question before it is anything else.
Here is the part within your control. You cannot make the net narrower. You cannot shorten the moratorium or soften the strike force. The one variable entirely in your hands is whether your documentation proves what you already know to be true — that your patients are eligible, that your clinical decisions are sound, and that your agency is exactly what it claims to be. In a wide-net environment, your chart is not paperwork. It is your proof of legitimacy.
What a reviewer actually sees
A reviewer does not see your intentions. They do not see the years you have spent building a clean program. They see the certification of terminal illness and the clinical findings underneath it — and they decide, from those findings alone, whether the story holds together. Three of the places that story most often falls apart map exactly to the data regulators are watching.
Eligibility and recertification
A note that reads “Patient remains appropriate for hospice. Continues to decline” states a conclusion and proves nothing. The defensible version shows the decline:
Weight 118 lbs, down from 131 five months ago — an 11% loss — with intake reduced to roughly 25% of meals offered and no offsetting edema. Now requires total assist for transfers; was standby-assist one period ago.
Both notes describe a declining patient. Only one lets a stranger see it.
Length of stay
The long-stay patient is the classic trigger. A dementia patient on service for nineteen months is not, by itself, evidence of anything — dementia has a long and uneven trajectory. But if eight consecutive recertifications read nearly identically, a reviewer sees a plateau on paper, regardless of what is happening in the home. The defense is not a shorter stay. It is documentation that captures continued decline within the long stay: the new pressure injury, the third aspiration-related infection in six months, the FAST progression from 7A to 7C, the albumin drifting from 3.4 to 2.9.
Live discharge rate
When a patient stabilizes beyond the point of eligibility, discharging them is the honest, compliant thing to do — but a discharge documented as a number on a spreadsheet looks very different from one documented as a clinical event. “Patient no longer meets hospice criteria” invites the question. This answers it before it is asked:
Patient’s heart failure has stabilized on optimized therapy: no hospitalizations in five months, weight stable without escalating diuretics, now ambulating 100+ feet and independent in 3/5 ADLs — trajectory no longer consistent with a six-month prognosis.
Dorothy: the long-stay chart, two ways
Consider Dorothy, an 84-year-old with end-stage Alzheimer’s dementia, on your service for nineteen months. On census-length alone, she is exactly the kind of chart a length-of-stay review pulls. Whether her stay is defensible has almost nothing to do with how long she has been enrolled and everything to do with what the last four recertification notes captured.
The weak chart says, period after period: “Advanced dementia. Nonverbal. Continues to decline. Remains appropriate for hospice.” Every word may be true. None of it proves continued decline, and four identical notes in a row read, to a reviewer, like a copy-paste — the single most common finding that turns a long stay into a denied claim.
The defensible chart tells the same nineteen months as a trajectory. At the start of the window, Dorothy was FAST 7A — speech down to a half-dozen intelligible words — ambulating with a two-person assist, taking about 60% of a mechanical-soft diet, weight 132 lbs, albumin 3.4. By the most recent recert she is FAST 7C: no intelligible speech, no longer ambulatory, taking roughly 25% of a pureed diet with intermittent coughing on thin liquids, weight 116 lbs, albumin 2.8. She has had two aspiration-related pneumonias and one stage 2 sacral pressure injury in the interval.
Here the hypoalbuminemia matters in two directions at once: it signals the catabolic, end-stage nutritional state, and it drives the dependent edema that can quietly mask true lean-body-mass loss — so the 16-pound drop likely understates how much tissue she has actually lost. Document both the weight and the edema, or the weight alone will mislead anyone reading it.
Same patient. Same nineteen months. One chart is a liability the day an ADR letter arrives. The other was ready to defend itself before the letter was ever sent.
Five questions before you sign
Whether you are a director spot-checking charts, a compliance officer building an internal audit, or a medical director reviewing a recertification, these five questions separate a note that proves legitimacy from one that merely asserts it:
- Could a reviewer who has never met this patient see the decline from the words on the page — or only the conclusion that the patient is declining?
- Does this recertification show change since the last period, or could it be the previous note copied forward?
- For a long-stay patient, is there a specific, dated clinical event in this interval that demonstrates continued progression?
- Are weight changes documented alongside edema and fluid status, so the number is not read in isolation?
- If this were the chart pulled in a length-of-stay or discharge-rate review, would it answer the reviewer’s question — or invite it?
Where Hospice Intelligence fits
Every recertification note your nurses strengthen is a note that is more likely to survive a review — and in this environment, a single significant audit finding can mean recoupment demands ranging from tens of thousands of dollars to, depending on scope, far more. That is the financial risk a wide net creates, and it is the risk defensible documentation is built to reduce. Hospice Intelligence reads your nurse’s recertification note, cross-references it against the full LCD criteria checklist for the patient’s primary diagnosis, and flags which criteria were captured and which were missed — giving the nurse a field to add the detail that applies, before the note is ever finalized and pasted into the EMR. It does not replace clinical judgment and it guarantees no outcome; it makes the specificity this article is about easier to reach on every note, and over time it trains the eye to look for those findings during the visit itself. That is documentation quality treated as what it now is: a financial-risk and program-integrity question, not just a clinical one.
The takeaway
You cannot control how wide the net is cast. You can control whether, when a stranger opens your chart, it proves what you already know — that your patients belong on your service and your agency is exactly what it says it is. In a crackdown, the agencies that can demonstrate medical necessity fastest are the ones whose documentation was already telling the clinical story. Legitimacy you cannot put on the page is legitimacy a reviewer cannot see.
A note on the guidelines: Medicare LCD criteria are clinical guidelines, not pass/fail thresholds, and oversight metrics are indicators that inform scrutiny — not automatic findings. Strong documentation strengthens the defensibility of a claim; it does not guarantee any audit outcome.
See how Hospice Intelligence strengthens recertification documentation in a real workflow — book a free demo at hospiceintelligence.com, or schedule directly: https://calendar.app.google/NndT5BcD5DY7duDi8